Workday (NASDAQ:WDAY – Get Free Report)‘s stock had its “market outperform” rating reiterated by research analysts at JMP ...

JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...

JMP Securities reiterated a Market Outperform rating on Sprinklr Inc (NYSE:CXM), with a steady price target of $17.00. The firm's analysts highlighted the company's current performance, which includes ...

Enova International (NYSE:ENVA – Free Report) had its target price upped by JMP Securities from $125.00 to $135.00 in a ...

JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...

JMP Securities analyst Jason Butler maintained a Buy rating on Cytokinetics (CYTK – Research Report) today and set a price target of $78.00.

Wall Street analysts rerated Cloudflare, Inc (NYSE:NET) after the company released its fourth-quarterly print Thursday.

Covering some solid dividend stocks for JMP, analyst Aaron Hecht sees a reason to bet on higher value in the coming year. He notes that multiple tailwinds are coming together, and will likely lead ...

周五，JMP Securities重申了对Sprinklr Inc (NYSE: CXM )的"市场跑赢"评级，维持目标价17.00美元不变。该公司分析师强调了公司当前的业绩表现，包括第三财季8%的增长和12%的营业利润率。公司展现出稳健的基本面，过去十二个月毛利率达73.29%，营收为7.8806亿美元。根据 InvestingPro ...

周四，JMP Securities重申了对Cytokinetics（NASDAQ:CYTK）的"优于大市"评级和78.00美元的目标价。尽管该股周三大跌8.4%（相比之下XBI生物科技指数下跌1.4%），该机构仍维持这一评级。目前该股交易价格为46.17美元，接近其52周低点44.49美元。 InvestingPro ...

JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...